Yüklüyor......
Late Administration of Trastuzumab Emtansine Might Lead to Loss of Chance for Better Outcome in Patients with HER2-Positive Metastatic Breast Cancer
The optimal sequence of anti-human epidermal growth factor receptor 2 (HER2) therapies in metastatic breast cancer (MBC) is still undetermined. Physicians must therefore make decisions based on clinical trials and their own experience for the best treatment sequence in these patients. The objective...
Kaydedildi:
| Yayımlandı: | Breast Care (Basel) |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
S. Karger GmbH
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6170918/ https://ncbi.nlm.nih.gov/pubmed/30319330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000488794 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|